Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Generic Cardio Drugs Equal Brands
By:
Mike Havrilla
Tuesday, December 02, 2008 6:29 PM
Symbols:
HDIX
,
HITK
,
IPXL
,
MHS
,
MNTA
,
PRGO
,
TEVA
Email Article
Bookmark:
Font Size
Print Article
The Top 30 Rated Healthcare Cost Containment companies outpaced benchmark healthcare ETFs over the past year with a loss of just 2.7%, compared to losses of about 30% each for the Healthcare Sector SPDR (XLV) and iShares S&P Global Healthcare (IXJ), 18% for PowerShares Dynamic Pharma (PJP), 28% for Pharma HOLDRs, and 22% for iShares Dow Jones U.S. Pharma (IHE).
Next Page >>
<< Previous Page
1
2
Bookmark:
Email Article
Print Article
Related Stories
Research Related Stocks:
HDIX
,
HITK
,
IPXL
,
MHS
,
MNTA
,
PRGO
,
TEVA
,
More Articles on:
Medical
ProActive HavRx Stock Indexes: Highlights And Opportunities
Biostar Raises $3.6 Million
Bulls Back On Track?
Ford's Main Problem: The UAW's Crippling Job Classifications And Work Rules
Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution
Rate this Commentary
Comments
(0)
No Comments
Post Comment
Name:
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
Advertisement
Related Press Releases
Home Diagnostics Reports Third Quarter 2009 Financial Results
Teva Introduces Fexofenadine HCl and Pseudoephedrine HCl Extended-Release Tablets; An Alternative to Allegra-D® 12 Hour Tablets
Impax Laboratories Continues Trend of Solid Growth in Revenue, Profit and Earnings for the Third Quarter 2009
Teva Reports Third Quarter 2009 Results
Impax Laboratories Confirms Patent Challenge Relating to TRICOR® 48mg and 145mg Tablets
Popular Articles
Apple Inc (AAPL): Weaker Dollar Will Benefit Revenue Growth And Margins
By:
Financial Alchemist
GE's $19 Billion (And Increasing) Toxic Asset Sink Hole
By:
Tyler Durden
The Scariest Thing On Wall Street - FNM
By:
The Growth Stock Wire
Natural Gas Companies
By:
Keith Kohl
Hot Stocks: Google’s Drive For Dominance Extends Into The Burgeoning Smartphone Market
By:
Money Morning
Advertisement
Special Offers
Recent Articles by Mike Havrilla
Synta Pharma Proceeds with Clinical Trial
Cytori Therapeutics: Stock Profile and 2009 Outlook
Research Note on Synta Pharma (SNTA)
Trading FDA Decisions: 14 Extreme Trades
Stem Cell Index Soars on Lift of Funding Ban
Global Stem Cell and Regenerative Medicine Index
More Articles by:
Mike Havrilla
More Articles on:
Medical
Research Related Stocks:
HDIX
,
HITK
,
IPXL
,
MHS
,
MNTA
,
PRGO
,
TEVA
,
Subscribe to
Email Alerts
or
RSS feeds
for articles from more than 300 contributors and press releases, SEC filings and full text news from thousands of sources.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia